Dr. Gurpreet Singh Guliani

M.D | Addiction Psychiatry


  501 S Washington Ave, Scranton
     Pennsylvania, 18505-3814
  570-343-2383    Maps & Directions
Dr. Gurpreet Singh Guliani is a Scranton, Pennsylvania based psychiatrist who is specialized in Addiction Psychiatry. His current practice location is 501 S Washington Ave, Scranton. Patients can reach him at 570-343-2383. Dr. Gurpreet Singh Guliani is M.D in Addiction Psychiatry and his NPI number (Unique professional ID assigned by NPPES) is 1659971240.
Dr. Gurpreet Singh Guliani focuses on evaluation and treatment of individuals with alcohol, drug, or other substance-related disorders, and of individuals with dual diagnosis of substance-related and other psychiatric disorders.
Complete Profile:
Dr. Gurpreet Singh Guliani speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Gurpreet Singh Guliani
Specialization: Addiction Psychiatry
Gender:Male
Credentials: M.D
Practice Address:501 S Washington Ave, Scranton,
Pennsylvania, 18505-3814
Phone:570-343-2383
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1659971240
NPI Enumeration Date: 01 Nov, 2020
NPI Last Update On: 20 Apr, 2022

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Gurpreet Singh Guliani
501 6th St Apt 12f,
Brooklyn, New York
Zip: 11215-3649
Phone Number: 708-735-0127
Patients can reach Dr. Gurpreet Singh Guliani at 501 S Washington Ave, Scranton, Pennsylvania or can call to book an appointment on 570-343-2383.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.